Category: Newsletter

General practice teams are reminded that Levemir® (insulin detemir) is being discontinued, with existing stock expected to be exhausted by[…]

Weight management continues to be a major priority across primary care, with practices increasingly looking at how they can support[…]

If you use Healthcare Assistants (HCAs) to help deliver flu, there’s a fair chance you’ll run this year’s clinics much[…]

The National Academy for Social Prescribing (NASP) has launched new Green Social Prescribing Practitioner Guidance, providing practical support for organisations delivering[…]

The Department of Health and Social Care (DHSC) has issued an updated Medicines Supply Notification (MSN) regarding the discontinuation of Levemir[…]

The introduction of Inclisiran (Leqvio®) into the lipid management pathway has created an exciting opportunity for primary care to reduce[…]

In February 2025, two significant appeals relating to GP premises market rent reviews were successfully upheld in favour of practices.[…]

For the first time in four years, NHS England and the BMA’s General Practitioners Committee (GPC) have reached an agreement[…]

A Question of Fairness: Lessons from the Practice’s Breach Notice Appeal The recent decision by NHS Resolution to uphold a[…]